Contract Research organizations

Slides:



Advertisements
Similar presentations
Investigator Responsibilities in Clinical Research
Advertisements

Combination Products and Mutually Conforming Labeling David Eveleth Pfizer Inc.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
Pharmaceutical Development and Review Process Rev. 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
Overview of Good Clinical Practices (GCPs)
OverviewOverview – Preparation – Day in the Life – Earnings – Employment – Career Path Forecast – ResourcesPreparationDay in the LifeEarningsEmploymentCareer.
Regulatory Overview.
Good Clinical Practice (GCP)- An introduction Dr Noor Ibrahim Mohamed Sakian.
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
Pharmacovigilance obligations of the Pharmaceutical companies in India
Regulatory Authority Governing Clinical Trials Anthony J. Minisi, MD Director, Cardiology Fellowship Program.
Carolyn Hommel Good Clinical Practice Program FDA February 25, 2004
Janet Ellen Holwell, CCRC, CCRA President, NY Metropolitan Chapter of ACRP.
INTRODUCTION TO RA.
Fourth Annual Medical Research Summit Concurrent Session 4.05 – Managing CROs and SMOs from a Compliance Perspective Michael SwiatochaAprill 23, 2004.
Investigational New Drug Application (IND)
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
INDs : Does My Study Need One? Edith Paal UAMS Office of Research Compliance August 22, 2003.
Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
1. Re-Use of Clinical Care and of Clinical Trial Data A Contract Research Organisation (CRO) point of view EuroRec Conference 2009 Sarajevo Selina Sibbald.
PATRICIA KERBY, MPA HUMAN SUBJECTIONS PROTECTION COMPLIANCE OFFICER OFFICE OF RESEARCH COMPLIANCE What are the FDA’s expectations in 2010?
Important informations
ANJALI JADHAV ANKITA SINGH ANUJA AHIRE ANURADHA PRASAD BEVIN D’SOUZA.
Quality of Bioequivalence Data Alfredo García - Arieta Training workshop: Training of BE assessors, Kiev, October 2009.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Design Documentation Clint Kehres, Brian Krouse, Jenn Shafner.
AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)
1 Operation of the Prescription Drug User Fee Program Janet Woodcock, M.D. Deputy Commissioner for Operations November 14, 2005.
Marketing Career Project Renee Bass Pharmaceutical/Medical Marketing.
Center for Biologics Evaluation and Research, FDA Site Visit Introduction Kathryn M. Carbone, M.D. Associate Director for Research.
Quality & Regulatory Expectations of Outsourcing Oversight Nicky Dodsworth, VP Global Quality Assurance.
Using Australian Clinical Sites – Challenges for International Sponsors Prof A J (Tony) Webber Clinical Network Services Pty Ltd Brisbane, Australia.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
GCP (GOOD CLINICAL PRACTISE)
Clinical Trials.
Responsibilities of Sponsor, Investigator and Monitor
1 Promotion in Management and Research Tracks in Industry Magdalena Alonso-Galicia, PhD Cardiovascular Diseases Department Merck Research Laboratories.
CLINICAL TRIALS.
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
Responsibilities of Sponsor, Investigator and Monitor
Biotechnology R&D.
Investigator-initiated Research What Are your Responsibilities?
The Information Professional’s Role in Product Safety
FDA’s IDE Decisions and Communications
How to Put Together an IDE Application
The Many Careers of Pharmacy
How to Apply for and Receive Industry Funding for Investigator Sponsored Research Chuck Simonton MD, FACC, FSCAI Chief Medical Officer Abbott Vascular.
Adverse Event Reporting: Trials and Tribulations
REGULATORY PROBLEMS IN CARING OUT PRE- AND POST- AUTHORISATION CLINICAL TRIALS Dr Penka Decheva GCP Inspector, BDA.
First-in-Man, First In The USA: What’s The Difference?
Laura Mauri, MD, MSc Brigham and Women’s Hospital
Medical Device Evaluation Division,
Pharmacovigilance Market Application Development, Price Trends, Forecast by 2017 – 2024
Clinical Engineering Lecture (3).
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
Benefits of US EFS: A Clinical Perspective
Early Feasibility in the USA –An Academic View
US Early Feasibility Studies (EFS)
Roles and Responsibilities of the Clinical Research Team
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
FDA 21 CFR Part 11 Overview June 10, 2006.
Opening an IND: Investigator Perspective
Pharmaceuticals Industry
Code of Ethics for CDM Professionals
Code of Ethics for CDM Professionals
Presentation transcript:

Contract Research organizations A Business Overview Shannon Staton PharmD 2016

About Contract research organizations (CROs) provide clinical trial and other research support services for: Pharmaceutical industry Biotechnology industry Medical Device industry Government institutions Foundations Universities “A person or an organization (commercial, academic, other) contracted by the sponsor to perform one or more of a sponsors’ trial related duties and functions.”

Pharmaceutical Product Development: A CRO Company http://www.ppdi.com/About/CRO-Overview

References

Services Provided Project Management Database design & build Data entry & validation Clinical trial data management Medicine and disease coding Quality and metric reporting Statistical analysis plans and reports Validation programming Safety and efficacy summaries

Advantages = Cost Savings Organizations that contract with CROs are able to acquire specific expertise without having to hire permanent staff CROs reduce the time it takes to conduct a clinical trial versus an in-house trial

Regulatory Aspects Conducting proper clinical studies for submission to FDA and for the protection of the rights and welfare of subjects involved in clinical studies. Responsibilities: Obtain agency approval, where necessary, before studies begin. Manufacture and label investigational products appropriately. Initiate, withhold, or discontinue clinical trials as required. Refrain from commercialization of investigational products. Control the distribution and return of investigational products. Select qualified investigators to conduct studies. Disseminate appropriate information to investigators. Select qualified persons to monitor the conduct of studies. Adequately monitor clinical investigations. Evaluate and report adverse experiences. Maintain adequate records of studies. Submit progress reports and the final results of studies. Sponsors may transfer responsibility for any or all of these obligations to Contract Research Organizations (CROs) permitted by written agreement. Responsibilities that are not specified in a written agreement are not considered to be transferred. CROs are subject to the same regulatory actions as sponsors for any failure to perform any of the obligations assumed. Monitors are employed by sponsors or CROs to oversee the progress of an investigation.

Market Growth CROs are a relatively new Industry segment was extremely small a decade ago Analysts suggest the industry is growing by 4 to 12% annually Predicted increase from 30% to 60-80% outsourcing of clinical trials activities CRO sector generates over $30 billion The ten largest CROs control over 50% of the market share including: Quintiles Paraxel Covance Pharmaceutical Product Development Icon INC Research

Opportunities for Pharmacists There are a variety of career paths within CROs for pharmacists; responsibilities and approximate time spent on these: 30% research 15% project/case management 10% data management 8% business/organization/department management and service Two of the highest rated aspects of being a CRO pharmacist include: Applying scientific and medical knowledge Interacting with colleagues of different disciplines

References Background of Biosearch Monitoring. FDA, US Department of Health and Human Services, 2015. Available at: http://www.fda.gov/ICECI/EnforcementActions/BioresearchMonitoring/ucm134105.htm Silverman, E. Why Contract Organizations are So Hot. Forbes, 2011. Available at: http://www.forbes.com/sites/natalierobehmed/2015/09/11/how-akshay-kumar-became-one-of-the-worlds-highest-paid-actors/ Stone, K. Contract Research Organizations. About Money, 2012. Available at: http://pharma.about.com/od/C/g/Contract-Research-Organization-cro.htm Pharmaceutical Product Development, Available at: http://www.ppdi.com/